AVANTE CORP (XX.CA) Stock Fundamental Analysis

TSX-V:XX • CA05352F1099

1.08 CAD

0 (0%)

Last: Feb 24, 2026, 07:00 PM

Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Fundamental Rating

Overall XX gets a fundamental rating of 3 out of 10. We evaluated XX against 2 industry peers in the Diversified Consumer Services industry. The financial health of XX is average, but there are quite some concerns on its profitability. XX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability 2. Health 3. Growth 4. Valuation 5. Dividend

1. Profitability

1.1 Basic Checks

In the past year XX has reported negative net income.
XX had a positive operating cash flow in the past year.
XX had negative earnings in 4 of the past 5 years.
In multiple years XX reported negative operating cash flow during the last 5 years.

1.2 Ratios

XX has a Return On Assets (-3.88%) which is comparable to the rest of the industry.
The Return On Equity of XX (-7.06%) is comparable to the rest of the industry.
XX has a Return On Invested Capital (0.90%) which is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-3.88%
ROE	-7.06%
ROIC	0.9%

ROA(3y)-6.04%

ROA(5y)-6.99%

ROE(3y)-10.77%

ROE(5y)-16.93%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

XX's Operating Margin of 0.55% is in line compared to the rest of the industry. XX outperforms 50.00% of its industry peers.
XX's Gross Margin of 39.02% is in line compared to the rest of the industry. XX outperforms 50.00% of its industry peers.
XX's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	0.55%
PM (TTM)	N/A
GM	39.02%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.15%

GM growth 5Y10.86%

More info and screens

ROA ROE ROIC Operating and Profit Margin Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XX is destroying value.
XX has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, XX has more shares outstanding
The debt/assets ratio for XX is higher compared to a year ago.

2.2 Solvency

XX has an Altman-Z score of 2.34. This is not the best score and indicates that XX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of XX (2.34) is better than 100.00% of its industry peers.
XX has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
XX's Debt to FCF ratio of 0.85 is in line compared to the rest of the industry. XX outperforms 50.00% of its industry peers.
XX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of XX (0.05) is better than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	0.85
Altman-Z	2.34

ROIC/WACC0.11

WACC7.83%

2.3 Liquidity

XX has a Current Ratio of 1.81. This is a normal value and indicates that XX is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.81, XX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
XX has a Quick Ratio of 1.65. This is a normal value and indicates that XX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of XX (1.65) is better than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.81
Quick Ratio	1.65

More info and screens

WACC Debt/Equity How to determine the health of a company Altman-Z score Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 76.09% over the past year.
The Revenue has grown by 17.15% in the past year. This is quite good.
XX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.50% yearly.

EPS 1Y (TTM)76.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%110.36%

Revenue 1Y (TTM)17.15%

Revenue growth 3Y22.97%

Revenue growth 5Y-7.5%

Sales Q2Q%9.77%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XX indicates a rather cheap valuation: XX is cheaper than 100.00% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as XX.

		Industry Rank	Sector Rank
P/FCF	18.74
EV/EBITDA	13.86

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Price/Earnings Price/FCF FCF per share EV/EBITDA PEG RATIO Show best valued peers

5. Dividend

5.1 Amount

XX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks Show peers with best dividend

AVANTE CORP

TSX-V:XX (2/24/2026, 7:00:00 PM)

1.08

0 (0%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Services

GICS IndustryDiversified Consumer Services

Earnings (Last)11-24 2025-11-24

Earnings (Next)02-24 2026-02-24

Inst Owners0.12%

Inst Owner ChangeN/A

Ins Owners24.94%

Ins Owner ChangeN/A

Market Cap28.78M

Revenue(TTM)35.38M

Net Income(TTM)-893.50K

Analysts82.86

Price Target2.3 (112.96%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.81
P/FCF	18.74
P/OCF	11.08
P/B	2.27
P/tB	4.65
EV/EBITDA	13.86

EPS(TTM)-0.03

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.06

FCFY5.34%

OCF(TTM)0.1

OCFY9.02%

SpS1.33

BVpS0.47

TBVpS0.23

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.88%
ROE	-7.06%
ROCE	1.26%
ROIC	0.9%
ROICexc	1.24%
ROICexgc	2.93%
OM	0.55%
PM (TTM)	N/A
GM	39.02%
FCFM	4.34%

ROA(3y)-6.04%

ROA(5y)-6.99%

ROE(3y)-10.77%

ROE(5y)-16.93%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-3.15%

GM growth 5Y10.86%

F-Score6

Asset Turnover1.54

Health

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	0.85
Debt/EBITDA	0.37
Cap/Depr	63.87%
Cap/Sales	3%
Interest Coverage	250
Cash Conversion	140.08%
Profit Quality	N/A
Current Ratio	1.81
Quick Ratio	1.65
Altman-Z	2.34

F-Score6

WACC7.83%

ROIC/WACC0.11

Cap/Depr(3y)43.23%

Cap/Depr(5y)32.2%

Cap/Sales(3y)2.35%

Cap/Sales(5y)1.76%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)76.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%110.36%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)17.15%

Revenue growth 3Y22.97%

Revenue growth 5Y-7.5%

Sales Q2Q%9.77%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y107.86%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-68.63%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-53.67%

OCF growth 3Y-43.11%

OCF growth 5YN/A

AVANTE CORP / XX.CA FAQ

What is the ChartMill fundamental rating of AVANTE CORP (XX.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XX.CA.

Can you provide the valuation status for AVANTE CORP?

ChartMill assigns a valuation rating of 1 / 10 to AVANTE CORP (XX.CA). This can be considered as Overvalued.

Can you provide the profitability details for AVANTE CORP?

AVANTE CORP (XX.CA) has a profitability rating of 2 / 10.

Can you provide the financial health for XX stock?

The financial health rating of AVANTE CORP (XX.CA) is 6 / 10.